TB Times: When it comes to St. Pete's Trop site, plan before you build | Column
TB Times: Explain what I can bring into a Florida Publix | Column
TB Times: Halloween costumes that will offend absolutely no one | Column
TB Times: What would Erma Bombeck do? | Column
TB Times: Adults need to use their imaginations | Column
TB Times: Is this the Rapture? | Column
TB Times: New slogans for Tylenol | Column
TB Times: The Obama Main Library lends St. Pete a very good day | Column
TB Times: Florida's richest crab thrilled by shady Destin land purchase | Column
TB Times: It's false fall in Tampa Bay, and the delusion tastes great | Column
Today's Stories
NYTimes: Trump and Biden Joust in Florida, Looking for Votes in the Margins
NBC News: Why Biden ties Florida, leads in Pennsylvania
News4Jax: Biden faces worries that Latino support slipping in Florida
FlaPol: Marco Rubio to Disney: Xinjiang? Seriously?
Sun-Sentinel: Many Canadian snowbirds are delaying Florida visits until COVID-19 eases
Times: Trump's policy agenda gets Florida focus in election year
ABC News: Florida's surprising new battleground county
My News 13: Biden to Visit Tampa, Kissimmee in 1st Florida Trip Since COVID-19
CBS Miami: Florida To Begin Paying Extra $300 "Lost Wages" Benefit To Unemployed Floridians
Sentinel: Florida reports 2,423 new coronavirus cases, 8 more resident deaths
Sun-Sentinel: Overdoses rise in South Florida as people struggle with isolation from pandemic
Miami Herald: Feds' drilling plan gives Florida Democrats, Republicans something to agree on
Orlando Sentinel: RFK Jr. says he personally directed CDC's new guidance on vaccines and autism
Sun Sentinel: Florida DOGE seeks information on every course taught at universities
Orlando Sentinel: DeSantis: Plan for oil drilling off Florida coast would 'weaken protections'
Sun Sentinel: He was Zohran Mamdani's Jewish wingman. What's next for Brad Lander?
Orlando Sentinel: Progress on overdose deaths could be jeopardized by federal cuts, critics say
Orlando Sentinel: FDA's plan to boost biosimilar drugs could stall at the patent office
